These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15234630)

  • 1. The truth about quality: medical usefulness and analytical reliability of laboratory tests.
    Westgard JO; Darcy T
    Clin Chim Acta; 2004 Aug; 346(1):3-11. PubMed ID: 15234630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol operational process specifications for assuring the quality required by CLIA proficiency testing.
    Westgard JO; Wiebe DA
    Clin Chem; 1991 Nov; 37(11):1938-44. PubMed ID: 1934469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charts of operational process specifications ("OPSpecs charts") for assessing the precision, accuracy, and quality control needed to satisfy proficiency testing performance criteria.
    Westgard JO
    Clin Chem; 1992 Jul; 38(7):1226-33; discussion 1245-50. PubMed ID: 1623586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical usefulness of glucated haemoglobin in diabetes care evaluated by use of a medical technology assessment strategy.
    Larsen ML
    Dan Med Bull; 1997 Jun; 44(3):303-15. PubMed ID: 9233549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allowable imprecision for laboratory tests based on clinical and analytical test outcome criteria.
    Westgard JO; Seehafer JJ; Barry PL
    Clin Chem; 1994 Oct; 40(10):1909-14. PubMed ID: 7923771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol--a model system to relate medical needs with analytical performance.
    Wiebe DA; Westgard JO
    Clin Chem; 1993 Jul; 39(7):1504-12; discussion 1512-3. PubMed ID: 8330412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision Limits.
    Hyltoft Petersen P; Klee GG
    Clin Chim Acta; 2014 Mar; 430():1-8. PubMed ID: 24362233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test result variation and the quality of evidence-based clinical guidelines.
    Fraser CG
    Clin Chim Acta; 2004 Aug; 346(1):19-24. PubMed ID: 15234632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of current National Cholesterol Education Program guidelines for total cholesterol triglyceride, HDL-cholesterol, and LDL-cholesterol measurements.
    Caudill SP; Cooper GR; Smith SJ; Myers GL
    Clin Chem; 1998 Aug; 44(8 Pt 1):1650-8. PubMed ID: 9702951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory process specifications for assuring quality in the U.S. National Cholesterol Education Program.
    Westgard JO; Petersen PH; Wiebe DA
    Clin Chem; 1991 May; 37(5):656-61. PubMed ID: 2032319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of NCEP performance specifications for triglycerides, HDL-, and LDL-cholesterol with operating specifications based on NCEP clinical and analytical goals.
    Fallest-Strobl PC; Olafsdottir E; Wiebe DA; Westgard JO
    Clin Chem; 1997 Nov; 43(11):2164-8. PubMed ID: 9365403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical goal-setting for monitoring patients when two analytical methods are used.
    Petersen PH; Fraser CG; Westgard JO; Larsen ML
    Clin Chem; 1992 Nov; 38(11):2256-60. PubMed ID: 1424120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European specifications for imprecision and inaccuracy compared with operating specifications that assure the quality required by US CLIA proficiency-testing criteria.
    Westgard JO; Seehafer JJ; Barry PL
    Clin Chem; 1994 Jul; 40(7 Pt 1):1228-32. PubMed ID: 8013091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Governmental perspectives on evaluating laboratory performance.
    Boone DJ
    Clin Chem; 1993 Jul; 39(7):1461-5; discussion 1466-7. PubMed ID: 8330408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Error budgets for quality management--practical tools for planning and assuring the analytical quality of laboratory testing processes.
    Westgard JO
    Clin Lab Manage Rev; 1996; 10(4):377-81, 384-93, 396-403. PubMed ID: 10172718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory standardization of a large international clinical trial: the DAIS experience. DAIS Project Group. Diabetes Atherosclerosis Intervention Study.
    McGuinness C; Seccombe DW; Frohlich JJ; Ehnholm C; Sundvall J; Steiner G
    Clin Biochem; 2000 Feb; 33(1):15-24. PubMed ID: 10693982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can current analytical quality performance of UK clinical laboratories support evidence-based guidelines for diabetes and ischaemic heart disease?--A pilot study and a proposal.
    Jassam N; Yundt-Pacheco J; Jansen R; Thomas A; Barth JH
    Clin Chem Lab Med; 2013 Aug; 51(8):1579-84. PubMed ID: 23525878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory precision performance: state of the art versus operating specifications that assure the analytical quality required by clinical laboratory improvement amendments proficiency testing.
    Westgard JO; Bawa N; Ross JW; Lawson NS
    Arch Pathol Lab Med; 1996 Jul; 120(7):621-5. PubMed ID: 8757464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical performance specifications based on how clinicians use laboratory tests. Experiences from a post-analytical external quality assessment programme.
    Thue G; Sandberg S
    Clin Chem Lab Med; 2015 May; 53(6):857-62. PubMed ID: 25883204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How good are clinical laboratories? An assessment of current performance.
    Rej R; Jenny RW
    Clin Chem; 1992 Jul; 38(7):1210-7; discussion 1218-25. PubMed ID: 1623585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.